Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients. Participants were vaccinated with two-dose inactivated SARS-CoV-2 vaccine (V2) and a third dose of ChAdOx1 nCoV-19 vaccine (V3) a...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Jackrapong Bruminhent, Chavachol Setthaudom, Rungthiwa Kitpermkiat, Sasisopin Kiertiburanakul, Kumthorn Malathum, Montira Assanatham, Arkom Nongnuch, Angsana Phuphuakrat, Pongsathon Chaumdee, Chitimaporn Janphram, Sansanee Thotsiri, Piyatida Chuengsaman, Sarinya Boongird
مؤلفون آخرون:	Faculty of Medicine Ramathibodi Hospital, Mahidol University
التنسيق:	مقال
منشور في:	2022
الموضوعات:	Multidisciplinary
الوصول للمادة أونلاين:	https://repository.li.mahidol.ac.th/handle/123456789/75424
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
المؤسسة:	Mahidol University

مواد مشابهة

Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3)
بواسطة: Sarinya Boongird, وآخرون
منشور في: (2022)

SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)
بواسطة: Jackrapong Bruminhent, وآخرون
منشور في: (2022)

Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report
بواسطة: Sarinya Boongird, وآخرون
منشور في: (2022)

Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine
بواسطة: Sarinya Boongird, وآخرون
منشور في: (2022)

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
بواسطة: Bruminhent J.
منشور في: (2023)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
بواسطة: Ane Ogbe, وآخرون
منشور في: (2022)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
بواسطة: Ogbe A.
منشور في: (2023)

Vaccine-induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV-19 is rare in Asia
بواسطة: Kochawan Boonyawat, وآخرون
منشور في: (2022)

Vaccine-induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV-19 is rare in Asia
بواسطة: Boonyawat K.
منشور في: (2023)

Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers
بواسطة: Siriorn P. Watcharananan, وآخرون
منشور في: (2022)

An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study)
بواسطة: Jackrapong Bruminhent, وآخرون
منشور في: (2022)

Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine
بواسطة: Yasunori Watanabe, وآخرون
منشور في: (2022)

Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination - can it be explained by the two-hit hypothesis?
بواسطة: Parakh, Shweta, وآخرون
منشور في: (2023)

Rates, types, and associated factors of acute adverse effects after the first dose of ChAdOx1 nCoV-19 vaccine administration in Thailand
بواسطة: Watcharananan S.A.
منشور في: (2023)

Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers
بواسطة: Watcharananan S.P.
منشور في: (2023)

Prevalence of anti–platelet factor 4/polyanionic antibodies after COVID-19 vaccination with ChAdOx1 nCoV-19 and CoronaVac in Thais
بواسطة: Phichchapha Noikongdee, وآخرون
منشور في: (2022)

Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais
بواسطة: Boonyawat K.
منشور في: (2023)

Safety and immunogenicity of intradermal administration of fractional dose CoronaVac<sup>®</sup>, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
بواسطة: Chatsiricharoenkul S.
منشور في: (2023)

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
بواسطة: John Frater, وآخرون
منشور في: (2022)

Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
بواسطة: Pang, Junxiong, وآخرون
منشور في: (2020)

Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3)
بواسطة: Boongird S.
منشور في: (2023)

How Should the Rehabilitation Community Prepare for 2019-nCoV?
بواسطة: Choon-Huat Koh, G, وآخرون
منشور في: (2022)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
بواسطة: Suvimol Niyomnaitham, وآخرون
منشور في: (2022)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
بواسطة: Niyomnaitham S.
منشور في: (2023)

Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial
بواسطة: Niyomnaitham S.
منشور في: (2023)

The Effect of a Booster Dose mRNA Vaccine on COVID-19 Infection in Kidney Transplant Recipients after Inactivated or Viral Vector Vaccine Immunization
بواسطة: Thotsiri S.
منشور في: (2023)

Response to Letter Regarding “How Should the Rehabilitation Community Prepare for 2019-nCoV?”
بواسطة: Hoenig, H, وآخرون
منشور في: (2022)

SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)
بواسطة: Bruminhent J.
منشور في: (2023)

Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
بواسطة: Nicole L. Yates, وآخرون
منشور في: (2018)

Graves’ disease following SARS-CoV-2 vaccination
بواسطة: Chutintorn Sriphrapradang, وآخرون
منشور في: (2022)

Development of SARS-CoV-2 Vaccine: Challenges and Prospects
بواسطة: Mahboob T.
منشور في: (2023)

Immunogenicity and efficacy of zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines
بواسطة: César López-Camacho, وآخرون
منشور في: (2020)

Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update
بواسطة: Pimsiri Sripongpun, وآخرون
منشور في: (2022)

Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients
بواسطة: Napun Sutharattanapong, وآخرون
منشور في: (2022)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
بواسطة: Nicos Karasavvas, وآخرون
منشور في: (2018)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
بواسطة: Nicos Karasavvas, وآخرون
منشور في: (2018)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
بواسطة: Nicos Karasavvas, وآخرون
منشور في: (2018)

Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting
بواسطة: Sai Kit Lam, وآخرون
منشور في: (2018)

Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting
بواسطة: Sai Kit Lam, وآخرون
منشور في: (2015)

Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting
بواسطة: Lam, S.K., وآخرون
منشور في: (2014)